| |
| |
|
| Insider
Information: |
Hansen Carl L. G. |
| Relationship: |
Chief Executive Office... |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
729,625 |
|
|
Indirect Shares
|
55,802,493 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,532,118 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abcellera Biologics Inc. |
ABCL |
Chief Executive Office... |
2024-02-26 |
729,625 |
2024-02-26 |
55,802,493 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2024-02-26 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
729,625 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2023-11-23 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
673,500 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2023-08-24 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
617,375 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2023-05-26 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
561,250 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2023-02-22 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
505,125 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2022-11-18 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
449,000 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2022-08-18 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
392,875 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2022-05-18 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
336,750 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2022-02-22 |
4 |
OE |
$2.70 |
$151,538 |
D/D |
56,125 |
280,625 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive Officer |
• • • |
2021-06-09 |
4 |
S |
$24.03 |
$144,770,323 |
I/I |
(6,000,000) |
233,500 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Chief Executive OfficerOfficer |
• • • |
2020-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
61,827,830 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
